{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T22:32:26Z","timestamp":1785450746197,"version":"3.56.0"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,2,15]],"date-time":"2018-02-15T00:00:00Z","timestamp":1518652800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["RSF grant No. 17-75-10053"],"award-info":[{"award-number":["RSF grant No. 17-75-10053"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2018.00111","type":"journal-article","created":{"date-parts":[[2018,2,14]],"date-time":"2018-02-14T23:27:56Z","timestamp":1518650876000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Triple-Gene Therapy for Stroke: A Proof-of-Concept in Vivo Study in Rats"],"prefix":"10.3389","volume":"9","author":[{"given":"Mikhail E.","family":"Sokolov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farid V.","family":"Bashirov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vage A.","family":"Markosyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana V.","family":"Povysheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip O.","family":"Fadeev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey A.","family":"Izmailov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxim S.","family":"Kuztetsov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zufar Z.","family":"Safiullov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxim M.","family":"Shmarov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris S.","family":"Naroditskyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e1s","family":"Palot\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rustem R.","family":"Islamov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,2,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/jnr.20968","article-title":"Gene delivery to the spinal cord: comparison between lentiviral, adenoviral, and retroviral vector delivery systems.","volume":"84","author":"Abdellatif","year":"2006","journal-title":"J. Neurosci. Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"737","DOI":"10.15252\/emmm.201707573","article-title":"Gene therapy for ADA-SCID, the first marketing approval of an ex vivo gene therapy in Europe: paving the road for the next generation of advanced therapy medicinal products.","volume":"9","author":"Aiuti","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1182\/blood-2013-02-453175","article-title":"Umbilical cord blood transplantation: the first 25 years and beyond.","volume":"122","author":"Ballen","year":"2013","journal-title":"Blood"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.3727\/096368911X589609","article-title":"Determination of the therapeutic time window for human umbilical cord blood mononuclear cell transplantation following experimental stroke in rats.","volume":"21","author":"Boltze","year":"2012","journal-title":"Cell Transplant."},{"key":"B5","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1126\/science.1171242","article-title":"Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy.","volume":"326","author":"Cartier","year":"2009","journal-title":"Science"},{"key":"B6","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1126\/science.288.5466.669","article-title":"Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease.","volume":"288","author":"Cavazzana-Calvo","year":"2000","journal-title":"Science"},{"key":"B7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.5137\/1019-5149.JTN.11488-14.3","article-title":"Protective effect of ad-vegf-bone mesenchymal stem cells on cerebral infarction.","volume":"26","author":"Chen","year":"2015","journal-title":"Turk. Neurosurg."},{"key":"B8","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/j.1365-2362.2005.01565.x","article-title":"Combined cord blood stem cells and gene therapy enhances angiogenesis and improves cardiac performance in mouse after acute myocardial infarction.","volume":"35","author":"Chen","year":"2005","journal-title":"Eur. J. Clin. Invest."},{"key":"B9","first-page":"1225","article-title":"Regulation of naotai recipe on the expression of HIF-l\u03b1\/VEGF signaling pathway in cerebral ischemia\/reperfusion rats.","volume":"34","author":"Chen","year":"2014","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"key":"B10","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/jnr.10303","article-title":"Neuroprotection of glial cell line-derived neurotrophic factor in damaged spinal cords following contusive injury.","volume":"69","author":"Cheng","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.3727\/096368915X690279","article-title":"Safety and therapeutic potential of M2 macrophages in stroke treatment.","volume":"25","author":"Chernykh","year":"2016","journal-title":"Cell Transplant."},{"key":"B12","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.tips.2015.08.004","article-title":"L1-CAM and N-CAM: from adhesion proteins to pharmacological targets.","volume":"36","author":"Colombo","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2016.00034","article-title":"Evaluation of gene therapy as an intervention strategy to treat brain injury from stroke.","volume":"9","author":"Craig","year":"2016","journal-title":"Front. Mol. Neurosci."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1186\/scrt292","article-title":"Highly efficient differentiation of neural precursors from human embryonic stem cells and benefits of transplantation after ischemic stroke in mice.","volume":"4","author":"Drury-Stewart","year":"2013","journal-title":"Stem Cell Res. Ther."},{"key":"B15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1210\/edrv-13-1-18","article-title":"Molecular and biological properties of the vascular endothelial growth factor family of proteins.","volume":"13","author":"Ferrara","year":"1992","journal-title":"Endocr. Rev."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1001\/jama.2015.3253","article-title":"Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome.","volume":"313","author":"Hacein-Bey Abina","year":"2015","journal-title":"JAMA"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.3727\/096368916X692627","article-title":"The dose of intravenously transplanted bone marrow stromal cells determines the therapeutic effect on vascular remodeling in a rat model of ischemic stroke.","volume":"25","author":"He","year":"2016","journal-title":"Cell Transplant."},{"key":"B18","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/S0014-4886(03)00188-2","article-title":"Glial cell line-derived neurotrophic factor-enriched bridging transplants promote propriospinal axonal regeneration and enhance myelination after spinal cord injury.","volume":"183","author":"Iannotti","year":"2003","journal-title":"Exp. Neurol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1291\/hypres.27.119","article-title":"Development of angiogenic cell and gene therapy by transplantation of umbilical cord blood with vascular endothelial growth factor gene.","volume":"27","author":"Ikeda","year":"2004","journal-title":"Hypertens. Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1097\/00001756-200409150-00024","article-title":"Induction of VEGF and its Flt-1 receptor after sciatic nerve crush injury.","volume":"15","author":"Islamov","year":"2004","journal-title":"Neuroreport"},{"key":"B21","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.brainresbull.2017.05.005","article-title":"Evaluation of direct and cell-mediated triple-gene therapy in spinal cord injury in rats.","volume":"132","author":"Islamov","year":"","journal-title":"Brain Res. Bull."},{"key":"B22","doi-asserted-by":"publisher","first-page":"4756","DOI":"10.1007\/s12035-016-0017-x","article-title":"Tandem delivery of multiple therapeutic genes using umbilical cord blood cells improves symptomatic outcomes in ALS.","volume":"54","author":"Islamov","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"266","DOI":"10.2174\/1566523215666150126122317","article-title":"Symptomatic improvement, increased life-span and sustained cell homing in amyotrophic lateral sclerosis after transplantation of human umbilical cord blood cells genetically modified with adeno-viral vectors expressing a neuro-protective factor and a neur.","volume":"15","author":"Islamov","year":"2015","journal-title":"Curr. Gene Ther."},{"key":"B24","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.neulet.2017.02.034","article-title":"A pilot study of cell-mediated gene therapy for spinal cord injury in mini pigs.","volume":"644","author":"Islamov","year":"","journal-title":"Neurosci. Lett."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00813","article-title":"Spinal cord molecular and cellular changes induced by adenoviral vector- and cell-mediated triple gene therapy after severe contusion.","volume":"8","author":"Izmailov","year":"2017","journal-title":"Front. Pharmacol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.15283\/ijsc.2014.7.2.63","article-title":"Efficacy and safety of stem cell therapies for patients with stroke: a systematic review and single arm meta-analysis.","volume":"7","author":"Jeong","year":"2014","journal-title":"Int. J. Stem Cells"},{"key":"B27","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/S0301-472X(98)00039-3","article-title":"Marrow sensitization to 5-fluorouracil using the ligands for Flt-3 and c-Kit.","volume":"27","author":"Jin","year":"1999","journal-title":"Exp. Hematol."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1186\/scrt434","article-title":"Intraarterial transplantation of human umbilical cord blood mononuclear cells is more efficacious and safer compared with umbilical cord mesenchymal stromal cells in a rodent stroke model.","volume":"5","author":"Karlupia","year":"2014","journal-title":"Stem Cell Res. Ther."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1161\/01.STR.0000236025.44089.e1","article-title":"Intracerebral infusion of glial cell line-derived neurotrophic factor promotes striatal neurogenesis after stroke in adult rats.","volume":"37","author":"Kobayashi","year":"2006","journal-title":"Stroke"},{"key":"B30","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.brainres.2009.12.001","article-title":"Transplantation of placenta-derived mesenchymal stromal cells upon experimental stroke in rats.","volume":"1315","author":"Kranz","year":"2010","journal-title":"Brain Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1002\/glia.23017","article-title":"Anti-inflammatory effects of ADAMTS-4 in a mouse model of ischemic stroke.","volume":"64","author":"Lemarchant","year":"2016","journal-title":"Glia"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1186\/scrt79","article-title":"Therapeutic effects of human umbilical cord blood-derived mesenchymal stem cells after intrathecal administration by lumbar puncture in a rat model of cerebral ischemia.","volume":"2","author":"Lim","year":"2011","journal-title":"Stem Cell Res. Ther."},{"key":"B33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.phrs.2009.10.002","article-title":"Viral vectors for neurotrophic factor delivery: a gene therapy approach for neurodegenerative diseases of the CNS.","volume":"61","author":"Lim","year":"2010","journal-title":"Pharmacol. Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1093\/brain\/awl207","article-title":"Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia.","volume":"129","author":"Liu","year":"2006","journal-title":"Brain"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064160","article-title":"Vector-free and transgene-free human iPS cells differentiate into functional neurons and enhance functional recovery after ischemic stroke in mice.","volume":"8","author":"Mohamad","year":"2013","journal-title":"PLOS ONE"},{"key":"B36","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.acthis.2014.12.001","article-title":"Propidium iodide (PI) stains Nissl bodies and may serve as a quick marker for total neuronal cell count.","volume":"117","author":"Niu","year":"2015","journal-title":"Acta Histochem."},{"key":"B37","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.neuroscience.2005.06.062","article-title":"I.V. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat.","volume":"136","author":"Nomura","year":"2005","journal-title":"Neuroscience"},{"key":"B38","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.jalz.2013.09.004","article-title":"A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer\u2019s disease.","volume":"10","author":"Rafii","year":"2014","journal-title":"Alzheimers Dement."},{"key":"B39","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1517\/17425247.2016.1144588","article-title":"Targeted delivery of growth factors in ischemic stroke animal models.","volume":"13","author":"Rhim","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"B40","doi-asserted-by":"publisher","first-page":"7086","DOI":"10.1073\/pnas.95.12.7086","article-title":"Patterns of brain angiogenesis after vascular endothelial growth factor administration in vitro and in vivo.","volume":"95","author":"Rosenstein","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B41","first-page":"1","article-title":"Homing and survivability of genetically modified mononuclear umbilical cord blood cells after transplantation into transgenic G93A mice with amyotrophic lateral sclerosis.","volume":"10","author":"Safiullov","year":"2015","journal-title":"Genes Cells"},{"key":"B42","doi-asserted-by":"crossref","first-page":"76","DOI":"10.32607\/20758251-2014-76-84","article-title":"Protective immune response against Bacillus anthracis induced by intranasal introduction of a recombinant adenovirus expressing the protective antigen fused to the Fc-fragment of IgG2a.","volume":"6","author":"Shcherbinin","year":"2014","journal-title":"Acta Nat."},{"key":"B43","doi-asserted-by":"crossref","first-page":"5731","DOI":"10.1523\/JNEUROSCI.19-14-05731.1999","article-title":"Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system.","volume":"19","author":"Sondell","year":"1999","journal-title":"J. Neurosci."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2202-14-41","article-title":"Method parameters\u2019 impact on mortality and variability in rat stroke experiments: a meta-analysis.","volume":"14","author":"Str\u00f6m","year":"2013","journal-title":"BMC Neurosci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1007\/s12035-012-8388-0","article-title":"Repairing neural injuries using human umbilical cord blood.","volume":"47","author":"Sun","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/746068","article-title":"Microglial responses after ischemic stroke and intracerebral hemorrhage.","volume":"2013","author":"Taylor","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2014.00381","article-title":"Finding an optimal rehabilitation paradigm after stroke: enhancing fiber growth and training of the brain at the right moment.","volume":"8","author":"Wahl","year":"2014","journal-title":"Front. Hum. Neurosci."},{"key":"B48","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.brainres.2013.04.038","article-title":"Umbilical cord blood cells regulate endogenous neural stem cell proliferation via hedgehog signaling in hypoxic ischemic neonatal rats.","volume":"1518","author":"Wang","year":"2013","journal-title":"Brain Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/ana.24436","article-title":"Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: a double-blind, randomized, controlled trial.","volume":"78","author":"Warren Olanow","year":"2015","journal-title":"Ann. Neurol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"999","DOI":"10.3727\/096368909X471233","article-title":"Gene and Stem Cell Therapy in Ischemic Stroke.","volume":"18","author":"Yamashita","year":"2009","journal-title":"Cell Transplant."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-8-75","article-title":"Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditions.","volume":"8","author":"Yang","year":"2010","journal-title":"J. Transl. Med."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1186\/scrt224","article-title":"Human induced pluripotent stem cell-derived neural stem cells survive, migrate, differentiate, and improve neurologic function in a rat model of middle cerebral artery occlusion.","volume":"4","author":"Yuan","year":"2013","journal-title":"Stem Cell Res. Ther."},{"key":"B53","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1172\/JCI9369","article-title":"VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain.","volume":"106","author":"Zhang","year":"2000","journal-title":"J. Clin. Invest."},{"key":"B54","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.neuroscience.2015.01.038","article-title":"Enhanced angiogenesis promoted by human umbilical mesenchymal stem cell transplantation in stroked mouse is Notch1 signaling associated.","volume":"290","author":"Zhu","year":"2015","journal-title":"Neuroscience"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2018.00111\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T20:39:25Z","timestamp":1570739965000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2018.00111\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,15]]},"references-count":54,"alternative-id":["10.3389\/fphar.2018.00111"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2018.00111","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,15]]},"article-number":"111"}}